litlas
Log inCreate account

Paolo Calabresi

Active 1985–2025

273
Papers
35,833
Citations
112
h-index
259
i10-index

Citations

Citations per year for Paolo Calabresi1963: 1 citations1983: 2 citations1984: 1 citations1986: 1 citations1987: 5 citations1988: 6 citations1989: 3 citations1990: 16 citations1991: 14 citations1992: 40 citations1993: 37 citations1994: 46 citations1995: 70 citations1996: 63 citations1997: 104 citations1998: 120 citations1999: 155 citations2000: 195 citations2001: 177 citations2002: 183 citations2003: 277 citations2004: 301 citations2005: 250 citations2006: 279 citations2007: 304 citations2008: 306 citations2009: 316 citations2010: 393 citations2011: 328 citations2012: 264 citations2013: 238 citations2014: 289 citations2015: 308 citations2016: 257 citations2017: 266 citations2018: 286 citations2019: 933 citations2020: 1,314 citations2021: 1,345 citations2022: 1,127 citations2023: 953 citations2024: 1,346 citations2025: 730 citations2026: 22 citations1964–1982: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,603 citing papers, 24.5% of this breakdownItaly: 1,448 citing papers, 9.8% of this breakdownChina: 1,109 citing papers, 7.5% of this breakdownUnited Kingdom: 1,071 citing papers, 7.3% of this breakdownGermany: 799 citing papers, 5.4% of this breakdownFrance: 547 citing papers, 3.7% of this breakdownCanada: 512 citing papers, 3.5% of this breakdownSweden: 494 citing papers, 3.4% of this breakdownSpain: 459 citing papers, 3.1% of this breakdownJapan: 345 citing papers, 2.3% of this breakdownNetherlands: 305 citing papers, 2.1% of this breakdownIndia: 301 citing papers, 2.1% of this breakdown
0%24.5%Other 25.3%

Institutions

Fields

  • Medicine52.2%
  • Neuroscience28.8%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Psychology1%
  • Immunology and Microbiology0.9%
  • Engineering0.7%
  • Other2.7%

Topics

  • Parkinson's Disease Mechanisms and Treatments8.5%
  • Neuroscience and Neuropharmacology Research7.8%
  • Neurological disorders and treatments5.2%
  • Neurotransmitter Receptor Influence on Behavior3.5%
  • Alzheimer's disease research and treatments3.3%
  • Neuroinflammation and Neurodegeneration Mechanisms2.7%
  • Other69%

Coauthors

All papers

Open in search
  1. Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

    Authors: Paolo Calabresi, Alessandro Mechelli, Giuseppina Natale, Laura A. Volpicelli‐Daley, Giulia Di Lazzaro, Veronica Ghiglieri - Cell Death and Disease 2023 cited by 739

  2. Neurofilament light chain as a biomarker in neurological disorders

    Authors: Lorenzo Gaetani, Kaj Blennow, Paolo Calabresi, Massimiliano Di Filippo, Lucilla Parnetti, Henrik Zetterberg - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 1,327

  3. CSF and blood biomarkers for Parkinson's disease

    Authors: Lucilla Parnetti, Lorenzo Gaetani, Paolo Eusebi, Silvia Paciotti, Oskar Hansson, Omar M. A. El‐Agnaf, Brit Mollenhauer, Kaj Blennow, Paolo Calabresi - The Lancet Neurology 2019 cited by 671

  4. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Authors: José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl - Movement Disorders 2017 cited by 845

  5. Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease

    Authors: Paolo Calabresi, Giulia Di Lazzaro, Gioia Marino, Federica Campanelli, Veronica Ghiglieri - Brain 2023 cited by 150

  6. Direct and indirect pathways of basal ganglia: a critical reappraisal

    Authors: Paolo Calabresi, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Massimiliano Di Filippo - Nature Neuroscience 2014 cited by 823

  7. Levodopa in Parkinson’s Disease: Current Status and Future Developments

    Authors: Nicola Tambasco, Michele Romoli, Paolo Calabresi - Current Neuropharmacology 2017 cited by 280

  8. Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

    Authors: Alberto J. Espay, Francesca Morgante, Aristide Merola, Alfonso Fasano, Luca Marsili, Susan H. Fox, Erwan Bézard, Barbara Picconi, Paolo Calabresi, Anthony E. Lang - Annals of Neurology 2018 cited by 340

  9. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

    Authors: Michele Romoli, Petra Mazzocchetti, Renato D’Alonzo, Sabrina Siliquini, Victoria Elisa Rinaldi, Alberto Verrotti, Paolo Calabresi, Cinzia Costa - Current Neuropharmacology 2018 cited by 372

  10. Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis

    Authors: Paolo Eusebi, David Giannandrea, Leonardo Biscetti, Iosief Abraha, Davide Chiasserini, Massimiliano Orso, Paolo Calabresi, Lucilla Parnetti - Movement Disorders 2017 cited by 222

  11. Multiple sclerosis and cognition: synaptic failure and network dysfunction

    Authors: Massimiliano Di Filippo, Emilio Portaccio, Andrea Mancini, Paolo Calabresi - Nature reviews. Neuroscience 2018 cited by 219

  12. Dopamine-mediated regulation of corticostriatal synaptic plasticity

    Authors: Paolo Calabresi, Barbara Picconi, Alessandro Tozzi, Massimiliano Di Filippo - Trends in Neurosciences 2007 cited by 864

  13. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit

    Authors: Alessandro Tozzi, Miriam Sciaccaluga, Vittorio Loffredo, Alfredo Megaro, Ada Ledonne, Antonella Cardinale, Mauro Federici, Laura Bellingacci, Silvia Paciotti, Elena Ferrari, Antonino La Rocca, Alessandro Martini, Nicola Biagio Mercuri, Fabrizio Gardoni, Barbara Picconi, Veronica Ghiglieri, Elvira De Leonibus, Paolo Calabresi - Brain 2021 cited by 125

  14. Striatal glutamatergic hyperactivity in Parkinson's disease

    Authors: Federica Campanelli, Giuseppina Natale, Gioia Marino, Veronica Ghiglieri, Paolo Calabresi - Neurobiology of Disease 2022 cited by 79

  15. Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity

    Authors: Gioia Marino, Federica Campanelli, Giuseppina Natale, Maria De Carluccio, Federica Servillo, Elena Ferrari, Fabrizio Gardoni, Maria Emiliana Caristo, Barbara Picconi, Antonella Cardinale, Vittorio Loffredo, Francesco Crupi, Elvira De Leonibus, Maria Teresa Viscomi, Veronica Ghiglieri, Paolo Calabresi - Science Advances 2023 cited by 64

  16. Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

    Authors: Paraskevi Krashia, Alberto Cordella, Annalisa Nobili, Livia La Barbera, Mauro Federici, Alessandro Leuti, Federica Campanelli, Giuseppina Natale, Gioia Marino, Valeria Calabrese, Francescangelo Vedele, Veronica Ghiglieri, Barbara Picconi, Giulia Di Lazzaro, Tommaso Schirinzi, Giulia Maria Sancesario, Nicolas Casadei, Olaf Rieß, Sergio Bernardini, Antonio Pisani, Paolo Calabresi, Maria Teresa Viscomi, Charles N. Serhan, Valerio Chiurchiù, Marcello D’Amelio, Nicola Biagio Mercuri - Nature Communications 2019 cited by 181

  17. Amyloid-β: a potential link between epilepsy and cognitive decline

    Authors: Michele Romoli, Arjune Sen, Lucilla Parnetti, Paolo Calabresi, Cinzia Costa - Nature Reviews Neurology 2021 cited by 133

  18. Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease

    Authors: Lucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, Paolo Eusebi, Shiji Varghese, M. Mustafa Qureshi, Andrea Dardis, Marta Deganuto, Claudia De Carlo, Anna Castrioto, Chiara Balducci, Silvia Paciotti, Nicola Tambasco, Bruno Bembi, Laura Bonanni, Marco Onofrj, Aroldo Rossi, Tommaso Beccari, Omar M. A. El‐Agnaf, Paolo Calabresi - Movement Disorders 2014 cited by 273

  19. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

    Authors: Lorenzo Gaetani, Kina Höglund, Lucilla Parnetti, Fani Pujol-Calderón, Bruno Becker, Paolo Eusebi, Paola Sarchielli, Paolo Calabresi, Massimiliano Di Filippo, Henrik Zetterberg, Kaj Blennow - Alzheimer s Research & Therapy 2018 cited by 190

  20. Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients

    Authors: Lucilla Parnetti, Silvia Paciotti, Paolo Eusebi, Andrea Dardis, Stefania Zampieri, Davide Chiasserini, Anna Tasegian, Nicola Tambasco, Bruno Bembi, Paolo Calabresi, Tommaso Beccari - Movement Disorders 2017 cited by 175

  21. Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

    Authors: Lorenzo Gaetani, Francesca Boscaro, Giuseppe Pieraccini, Paolo Calabresi, Luigina Romani, Massimiliano Di Filippo, Teresa Zelante - Frontiers in Immunology 2020 cited by 71

  22. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis

    Authors: Massimiliano Di Filippo, Andrea Mancini, Laura Bellingacci, Lorenzo Gaetani, Petra Mazzocchetti, Teresa Zelante, Livia La Barbera, Antonella De Luca, Michela Tantucci, Alessandro Tozzi, Valentina Durante, Miriam Sciaccaluga, Alfredo Megaro, Davide Chiasserini, Nicola Salvadori, Viviana Lisetti, Emilio Portaccio, Cinzia Costa, Paola Sarchielli, Maria Pia Amato, Lucilla Parnetti, Maria Teresa Viscomi, Luigina Romani, Paolo Calabresi - Cell Reports 2021 cited by 85

  23. Proinflammatory Cytokines, Adhesion Molecules, and Lymphocyte Integrin Expression in the Internal Jugular Blood of Migraine Patients Without Aura Assessed Ictally

    Authors: Paola Sarchielli, Andrea Alberti, Antonio Baldi, Francesca Coppola, Cristiana Rossi, Laura Pierguidi, A. Floridi, Paolo Calabresi - Headache The Journal of Head and Face Pain 2006 cited by 302

  24. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies

    Authors: Tim E. Moors, Silvia Paciotti, Angela Ingrassia, Marialuisa Quadri, Guido J. Breedveld, Anna Tasegian, Davide Chiasserini, Paolo Eusebi, Gonzalo Durán-Pacheco, Thomas Kremer, Paolo Calabresi, Vincenzo Bonifati, Lucilla Parnetti, Tommaso Beccari, Wilma D. J. van de Berg - Molecular Neurobiology 2018 cited by 160